Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Sinergi Multi Lestarindo Tbk. (SMLE)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Sinergi Multi Lestarindo Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sinergi Multi Lestarindo Tbk. diperdagangkan di Rp185 (kapitalisasi pasar 444,68 M, volume 24 jam 19,41 jt). Perbedaan utamanya: Sinergi Multi Lestarindo Tbk. jauh lebih besar — sekitar 4,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SMLE | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 444,68 M |
Volume | — | 19,41 jt |
Lot | — | 194,13 rb |
Perputaran | — | 3,66 M |
Harga Rata-rata | — | 188,72 |
Nilai Transaksi | — | 3,66 M |
Harga Ekuilibrium Indikatif | — | 185 |
Volume Ekuilibrium Indikatif | — | 388 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Sinergi Multi Lestarindo Tbk.
PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Selengkapnya di halaman SMLE →
